Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sergiusz Nawrocki
Observed names:
Nawrocki, Sergiusz,
S Nawrocki,
S. Nawrocki
Institution:
University of Warmia and Mazury in Olsztyn
Observed institutions:
Poznan University of Medical Sciences,
Medical University of Silesia,
Greater Poland Cancer Center,
Uniwersytecki Szpital Kliniczny w Olsztynie,
Instytut Gruźlicy i Chorób Płuc,
University of Warsaw,
University of Warmia and Mazury in Olsztyn
show all 7
ORCID:
0000-0001-6225-6528
Observed ORCID:
0000-0001-6225-6528
OpenAlex ID:
A5071040712
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
2013
·
Charles Butts
, Mark A Socinski
, et al.
·
The Lancet Oncology
·
576
Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma
2000
·
Aldona Karczewska
, Sergiusz Nawrocki
, et al.
·
Cancer
·
65
PDF
Zalecenia ogólne dotyczące postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)
2017
·
Beata Kos-Kudła
, Jolanta Blicharz-Dorniak
, et al.
·
Endokrynologia Polska
·
64
PDF
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.
2013
·
Charles Andrew Butts
, Mark A. Socinski
, et al.
·
Journal of Clinical Oncology
·
61
COVID-19 Pandemic: Impact on Cancer Patients
2022
·
Monika Rucinska
, Sergiusz Nawrocki
·
International Journal of Environmental Research and Public Health
·
46
PDF
Genetically modified tumour vaccines – where we are today
1999
·
S. Nawrocki
, A. Mackiewicz
·
Cancer Treatment Reviews
·
36
Complementary and Alternative Medicine Use in Hospitalized Cancer Patients—Study from Silesia, Poland
2022
·
Karolina Kasprzycka
, Marta Kurzawa
, et al.
·
International Journal of Environmental Research and Public Health
·
34
PDF
Concurrent Chemotherapy and Short Course Radiotherapy in Patients with Stage IIIA to IIIB Non-small Cell Lung Cancer Not Eligible for Radical Treatment: Results of a Randomized Phase II Study
2010
·
Sergiusz Nawrocki
, Maciej Krzakowski
, et al.
·
Journal of Thoracic Oncology
·
34
PDF
Students’ Knowledge about Cervical Cancer Prevention in Poland
2021
·
Karolina Osowiecka
, Samira Yahuza
, et al.
·
Medicina
·
33
PDF
Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study
2023
·
Hongmei Zeng
, Mengyuan Xu
, et al.
·
EClinicalMedicine
·
32
PDF
Genetically modified tumour vaccines (GMTV) in melanoma clinical trials
2000
·
Sergiusz Nawrocki
, Paweł Murawa
, et al.
·
Immunology Letters
·
30
Consensus Statement on a Screening Programme for the Detection of Early Lung Cancer in Poland
2018
·
Witold Rzyman
, Joanna Didkowska
, et al.
·
Advances in respiratory medicine
·
27
PDF
SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment
2016
·
Monika Rucinska
, Anna Kieszkowska-Grudny
, et al.
·
Strahlentherapie und Onkologie
·
23
PDF
Numerical simulations for tumor and cellular immune system interactions in lung cancer treatment
2012
·
M. Kolev
, S. Nawrocki
, et al.
·
Communications in Nonlinear Science and Numerical Simulation
·
23
The Waiting Time of Prostate Cancer Patients in Poland
2019
·
Karolina Osowiecka
, Sergiusz Nawrocki
, et al.
·
International Journal of Environmental Research and Public Health
·
21
PDF
Clinical study and numerical simulation of brain cancer dynamics under radiotherapy
2014
·
S. Nawrocki
, B. Zubik-Kowal
·
Communications in Nonlinear Science and Numerical Simulation
·
19
Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer
2001
·
Sergiusz Nawrocki
, Piotr J Wysocki
, et al.
·
Expert Opinion on Biological Therapy
·
18
Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population-based study
2023
·
Ruiying Fu
, Ke Sun
, et al.
·
The Lancet Regional Health - Western Pacific
·
17
How Long Are Cancer Patients Waiting for Oncological Therapy in Poland?
2018
·
Karolina Osowiecka
, Monika Rucinska
, et al.
·
International Journal of Environmental Research and Public Health
·
17
PDF
Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study
2025
·
A.R. Filippi
, M.R. García Campelo
, et al.
·
ESMO Open
·
14
PDF
Improvements in Quality Control and Library Preparation for Targeted Sequencing Allowed Detection of Potentially Pathogenic Alterations in Circulating Cell-Free DNA Derived from Plasma of Brain Tumor Patients
2022
·
Paulina Szadkowska
, Adria-Jaume Roura
, et al.
·
Cancers
·
14
PDF
Patients’ Non-Medical and Organizational Needs during Cancer Diagnosis and Treatment
2020
·
Karolina Osowiecka
, Radoslaw Sroda
, et al.
·
International Journal of Environmental Research and Public Health
·
14
PDF
LBA62 Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study
2023
·
A.R.R. Filippi
, M.R. García-Campelo
, et al.
·
Annals of Oncology
·
13
PDF
Clinical trials of active cancer immunotherapy: where are the right end points?
2007
·
Sergiusz Nawrocki
, Andrzej Mackiewicz
·
Expert Opinion on Investigational Drugs
·
11
Pharmacotherapy of bladder cancer – practice and prospects
2002
·
Sergiusz Nawrocki
, Tomas Skacel
, et al.
·
Expert Opinion on Pharmacotherapy
·
11
Show more works
View as search
Works count:
137
Citation count:
1,438
H-index:
17
I10-index:
27
Year
Topic
Type